[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 5 sources · 2 days · First seen · Last updated

Cardiovascular health and menopause research

Overview

Medical research continues to investigate the physiological links between hormonal changes, cellular processes, and cardiovascular disease risk.

Studies involving the SWAN project suggest that hormone therapy initiated during perimenopause or early menopause may reduce the risk of cardiovascular disease by 22 to 27 percent. However, recent data highlights that the decline of estrogen levels alters vascular function, lipid metabolism, and blood pressure regulation, leading to endothelial dysfunction and systemic inflammation. Clinical findings indicate that cardiovascular diseases, including stroke and ischemic heart disease, are the primary causes of mortality and long-term disability among women, surpassing the combined mortality rates of breast, ovarian, and uterine cancers. Furthermore, the loss of hormonal protection is linked to acute events such as takotsubo cardiomyopathy, or ‘broken heart syndrome,’ which affects approximately 90 percent of patients over age 50.

In terms of cellular mechanisms, researchers at the University of Virginia Health have identified how the processing of nitrogen and glycogen in smooth muscle cells may influence the transition from protecting against plaque rupture to promoting plaque growth. This research identifies mannose, a simple sugar, as a potential factor in coronary artery disease development, offering a new avenue for preventative treatments.

Additionally, research has examined the impact of sleep patterns, noting that sleeping more than the recommended six to eight hours per night may be associated with increased risks of heart attack, heart failure, and mortality.

Entities

JAMA Internal Medicine · McMaster University · SWAN Study · European Heart Journal

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [HEALTH] 3 sources
    Cardiovascular health research identifies menopause risks and new plaque development drivers

    Medical studies highlight cardiovascular risks for menopausal women due to hormonal shifts and reveal how nitrogen and glycogen processing in smooth muscle cells may drive heart disease plaque development.

  2. [HEALTH] 2 sources
    Health studies link hormone therapy and sleep patterns to heart disease risk

    Recent studies link early hormone therapy in menopause to lower cardiovascular risk, while excessive sleep (over eight hours) is associated with increased heart disease and mortality risks.

Sources

diarioroatan.com · ekonomiaonline.com · gazetashneta.net · knowridge.com · world-today-journal.com

This summary has been updated 1 time: see revision history